International Clinical Trial: Effect of Prophylactic Low-Dose Droperidol on Postoperative Nausea and Vomiting in Gynecological Laparoscopic Surgery Patients and Its Impact on Perioperative QTc Interval

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132312) titled 'Effect of Prophylactic Low-Dose Droperidol on Postoperative Nausea and Vomiting in Gynecological Laparoscopic Surgery Patients and Its Impact on Perioperative QTc Interval' on Sept. 11.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Quzhou People Hospital

Condition: None

Intervention: Haloperidol group:Using a 1mL syringe (minimum scale 0.01mL), accurately draw 0.25 mL of droperidol stock solution (National Drug Approval No. H35020522, Fuzhou Cornerstone Pharmaceutical Technology Co., Ltd.), then inject this 0.25 mL of drug solution into a pre-labeled "study drug" 5 mL sterile sy...